Metabolism, Alcohol and Toxicity programme overview

This scientific track is an excellent opportunity for translational and basic researchers, clinicians, and industry stakeholders to gain knowledge on the rising prevalence of these diseases;  novel biomarkers and diagnostic tools; new drug targets; randomised control trial results; and the best approaches for treatment for NAFLD, ALD, and alcohol-related hepatitis.

Participants will hear from experts who will discuss what will shape the field in future years. The sessions will also provide a great opportunity for delegate networking and discussion; and for industry stakeholders to showcase results.